scispace - formally typeset
Open AccessJournal ArticleDOI

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis.

TLDR
The biological interplay between gut-brain axis is discussed, and how this communication may be dysregulated in neurological diseases is explored, and new insights in modification of gut microbiota composition are highlighted.
Abstract
Development of central nervous system (CNS) is regulated by both intrinsic and peripheral signals. Previous studies have suggested that environmental factors affect neurological activities under both physiological and pathological conditions. Although there is anatomical separation, emerging evidence has indicated the existence of bidirectional interaction between gut microbiota, i.e., (diverse microorganisms colonizing human intestine), and brain. The cross-talk between gut microbiota and brain may have crucial impact during basic neurogenerative processes, in neurodegenerative disorders and tumors of CNS. In this review, we discuss the biological interplay between gut-brain axis, and further explore how this communication may be dysregulated in neurological diseases. Further, we highlight new insights in modification of gut microbiota composition, which may emerge as a promising therapeutic approach to treat CNS disorders.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Toxicity of Microplastics and Nanoplastics in Mammalian Systems

TL;DR: The prevailing data suggest that micro- and nanoplastic accumulation in mammalian and human tissues would likely have negative, yet unclear long-term consequences, and there is a need for cellular and systemic toxicity due to micro-and nanoplastics to be better illuminated, and the underlying mechanisms defined by further work.
Journal ArticleDOI

The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.

TL;DR: The status of the knowledge and the open questions in the field focusing on the function of intestinal microbial metabolites or products on CNS cells during healthy and inflammatory conditions, such as multiple sclerosis, Alzheimer's and Parkinson’s diseases, and also neuropsychiatric disorders are discussed.
Journal ArticleDOI

Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.

TL;DR: As aging together with poor diet and gut-derived inflammatory response due to dysbiosis contributes to the pathogenesis of AD, modification of gut microbial composition by uptake of probiotic-rich food can act as a preventive/therapeutic option for AD.
Journal ArticleDOI

Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics.

TL;DR: Both benefits and pitfalls of molecular biology and proteomics analyses are discussed, including the different mass spectrometry-based analytical techniques, highlighting how these investigation strategies are powerful tools to study the biology of glioblastoma, as well as to develop advanced methods for the management of this pathology.
Journal ArticleDOI

Gut microbial molecules in behavioural and neurodegenerative conditions.

TL;DR: Bacterial metabolites with known or suspected neuromodulatory activity are described, mechanisms of signalling pathways from the gut microbiota to the brain are defined and direct effects that gut bacterial molecules are likely exerting on specific brain cells are discussed.
References
More filters
Journal ArticleDOI

Toll-like receptors modulate adult hippocampal neurogenesis

TL;DR: This study identified Toll-like receptors as players in adult neurogenesis and emphasizes their specified and diverse role in cell renewal.
Journal ArticleDOI

Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota.

TL;DR: This work sequenced bacterial 16S rRNA from fecal samples of Aβ precursor protein (APP) transgenic mouse model and found a remarkable shift in the gut microbiota as compared to non-transgenic wild-type mice, indicating a microbial involvement in the development of Abeta amyloid pathology and suggesting that microbiota may contribute to the developed neurodegenerative diseases.
Journal ArticleDOI

Characteristics of compounds that cross the blood-brain barrier

TL;DR: Two examples of drug delivery for newly discovered transporters are discussed: that for phosphorothioate oligonucleotides and for enzymes.
Journal ArticleDOI

Mining the Human Gut Microbiota for Immunomodulatory Organisms

TL;DR: This study broadly identifies the immunomodulatory effects of phylogenetically diverse human gut microbes and provides a foundation for investigation of gut microbiota-host mutualism, highlighting key players that could identify important therapeutics.
Related Papers (5)